1. Home
  2. UBCP vs ADAG Comparison

UBCP vs ADAG Comparison

Compare UBCP & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

UBCP

United Bancorp Inc.

N/A

Current Price

$13.85

Market Cap

78.4M

Sector

Finance

ML Signal

N/A

Logo Adagene Inc.

ADAG

Adagene Inc.

HOLD

Current Price

$2.02

Market Cap

90.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UBCP
ADAG
Founded
1902
2011
Country
United States
China
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.4M
90.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
UBCP
ADAG
Price
$13.85
$2.02
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.00
AVG Volume (30 Days)
4.3K
42.9K
Earning Date
02-06-2026
08-12-2025
Dividend Yield
6.88%
N/A
EPS Growth
N/A
N/A
EPS
1.31
N/A
Revenue
$30,516,000.00
$103,204.00
Revenue This Year
N/A
$4,446.34
Revenue Next Year
$5.59
$30.43
P/E Ratio
$10.37
N/A
Revenue Growth
4.40
N/A
52 Week Low
$12.25
$1.30
52 Week High
$15.64
$3.16

Technical Indicators

Market Signals
Indicator
UBCP
ADAG
Relative Strength Index (RSI) 48.00 57.08
Support Level $13.55 $1.69
Resistance Level $13.98 $1.98
Average True Range (ATR) 0.35 0.15
MACD -0.11 0.02
Stochastic Oscillator 31.02 89.81

Price Performance

Historical Comparison
UBCP
ADAG

About UBCP United Bancorp Inc.

United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which includes accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. It serves customers in Belmont, Harrison, Jefferson, Tuscarawas, Carroll, Athens, Hocking, and Fairfield counties and the surrounding localities. The bank also operates in Marshall County West Virginia.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.

Share on Social Networks: